Trevi Therapeutics, Inc. TRVI Earnings yield
Earnings yield at other companies
Other financials
Where this comes from
Calculated from Trevi Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Trevi Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Trevi Therapeutics, Inc.'s earnings yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Trevi Therapeutics, Inc.'s earnings yield?
- Trevi Therapeutics, Inc. (TRVI) reported earnings yield of -3% in Q1 2026.
- How has Trevi Therapeutics, Inc.'s earnings yield changed year-over-year?
- Trevi Therapeutics, Inc.'s earnings yield increased by 61.8% year-over-year, from -7.8% to -3%.
- What is the long-term trend for Trevi Therapeutics, Inc.'s earnings yield?
- Over 5 years (2020 to 2025), Trevi Therapeutics, Inc.'s earnings yield has grown at a -47.9% compound annual growth rate (CAGR), from -69.7% to -2.7%.
- What does earnings yield mean?
- Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.